Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000540998 | SCV000639887 | benign | Alpha thalassemia-X-linked intellectual disability syndrome | 2024-11-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001566773 | SCV001790342 | likely benign | not provided | 2020-12-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003159818 | SCV003880940 | likely benign | Inborn genetic diseases | 2023-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004735601 | SCV005342991 | likely benign | ATRX-related disorder | 2024-08-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |